Purchase disclosed
Opaleye Management
10% owner
Common Stock, par value $0.0001 per share
- Reported value
- $78.96K
- Reported price
- $2.0353 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Grace Therapeutics, Inc.
Last 30 daysInsiders bought $417.81K · 2 buyers, led by Prashant Kohli (CEO) with $214K. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
10% owner
Common Stock, par value $0.0001 per share
$408,202 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
2 buying groups inside 30 transaction-date days, public by the snapshot cutoff.
A reporting-owner group bought on at least two distinct dates within the cluster window.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
10% owner
Common Stock, par value $0.0001 per share
10% owner
Common Stock, par value $0.0001 per share
10% owner
Common Stock, par value $0.0001 per share
10% owner
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Common Stock, par value $0.0001 per share
10% owner
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Common Stock, par value $0.0001 per share
10% owner
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Common Stock, par value $0.0001 per share
Excluded from the common-share buying signal. See trade details.
10% owner
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Common Stock, par value $0.0001 per share
Excluded from the common-share buying signal. See trade details.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
10% owner
Common Stock, par value $0.0001 per share
10% owner
Common Stock, par value $0.0001 per share
Chief Executive Officer
Common Stock
VP Program Management
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Principal Financial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
10% owner
Common Stock, par value $0.0001 per share
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 38,796$2.04 / share | $78.96K | Oct 1Filed Oct 5 · 4d later | SEC filing |
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 20,000$2.07 / share | $41.37K | Oct 2Filed Oct 5 · 3d later | SEC filing |
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 1,694$2.06 / share | $3.49K | Oct 5Filed Oct 5 · 0d later | SEC filing |
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 7,849$2.09 / share | $16.4K | Sep 29Filed Oct 1 · 2d later | SEC filing |
10% ownerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Common Stock, par value $0.0001 per sharePurchase | 9,771$2.10 / share | $20.52K | Sep 21Filed Oct 1 · 10d later | SEC filing |
10% ownerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Common Stock, par value $0.0001 per sharePurchase | 5,318$2.10 / share | $11.17K | Sep 23Filed Oct 1 · 8d later | SEC filing |
10% ownerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Common Stock, par value $0.0001 per sharePurchaseExcluded from purchase score | 9,771$2.10 / share | Unavailable | Sep 21Filed Sep 23 · 2d later | SEC filing |
10% ownerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Common Stock, par value $0.0001 per sharePurchaseExcluded from purchase score | 5,318$2.10 / share | Unavailable | Sep 23Filed Sep 23 · 0d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units12,200Award · no purchase price | Non-cash award | Sep 17Filed Sep 21 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative unitsUnavailableAward · no purchase price | Non-cash award | Sep 17Filed Sep 21 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units12,200Award · no purchase price | Non-cash award | Sep 17Filed Sep 21 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units12,200Award · no purchase price | Non-cash award | Sep 17Filed Sep 21 · 4d later | SEC filing |
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 9,393$2.10 / share | $19.7K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 5,836$2.09 / share | $12.2K | Sep 9Filed Sep 10 · 1d later | SEC filing |
| Chief Executive Officer | Common StockPurchase | 100,000$2.14 / share | $214K | Sep 9Filed Sep 10 · 1d later | SEC filing |
| VP Program Management | Stock Option (Right to Buy)Grant or award | Derivative units35,760Award · no purchase price | Non-cash award | Aug 28Filed Sep 1 · 4d later | SEC filing |
| Chief Executive Officer | Stock Option (Right to Buy)Grant or award | Derivative units267,160Award · no purchase price | Non-cash award | Aug 28Filed Sep 1 · 4d later | SEC filing |
| Chief Medical Officer | Stock Option (Right to Buy)Grant or award | Derivative units54,690Award · no purchase price | Non-cash award | Aug 28Filed Sep 1 · 4d later | SEC filing |
| Principal Financial Officer | Stock Option (Right to Buy)Grant or award | Derivative units33,660Award · no purchase price | Non-cash award | Aug 28Filed Sep 1 · 4d later | SEC filing |
| 10% owner | Common Stock, par value $0.0001 per sharePurchase | 11,608$2.09 / share | $24.21K | Aug 14Filed Aug 19 · 5d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.